Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10524695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

  2010cited by this paper
• Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center.

  1999cited by this paper
• No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia

  1998cited by this paper
• Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia

  1998cited by this paper
• Cellular Networks in Hepatic Fibrosis

  1998cited by this paper
• [Peripheral neuropathies and chronic hepatitis C: a frequent association?].

  1998cited by this paper
• Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin Lymphoma

  1997cited by this paper
• The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association?

  1997cited by this paper
• Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.

  1997cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia.

  1997cited by this paper
• Hepatitis C Virus Genotype Analysis in Patients with Type II Mixed Cryoglobulinemia

  1996cited by this paper
• Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?

  1996cited by this paper
• Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia.

  1996cited by this paper
• Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection

  1996cited by this paper
• Hepatitis C.

  1996cited by this paper
• Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection.

  1996cited by this paper
• Sicca syndrome associated with hepatitis C virus infection.

  1996cited by this paper
• [Sicca syndrome and hepatitis C virus infection: a Gougerot-Sjögren pseudo-syndrome?].

  1996cited by this paper
• Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection

  1996cited by this paper
• Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis.

  1996cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• Hepatitis C virus and non‐Hodgkin's lymphomas

  1996cited by this paper
• Hepatitis C virus infection and porphyria cutanea tarda in Australasia.

  1996cited by this paper
• [Association of Gougerot-Sjögren syndrome and viral hepatitis C. Apropos of 6 cases].

  1995cited by this paper
• Can type C hepatitis infection be complicated by malignant lymphoma?

  1995cited by this paper
• Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in germany

  1995cited by this paper
• Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.

  1995cited by this paper
• Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus.

  1995cited by this paper
• Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations

  1995cited by this paper
• Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.

  1995cited by this paper
• Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus Serotypes

  1995cited by this paper
• Porphyria cutanea tarda and hepatitis C viral infection. A clinical and virologic study.

  1995cited by this paper
• High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C

  1995cited by this paper
• Lichen planus and hepatitis C virus infection: an epidemiologic study.

  1994cited by this paper
• [Prevalence and significance of non-specific anti-organelle antibodies of the liver in chronic viral hepatitis C].

  1994cited by this paper
• Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study

  1994cited by this paper
• [Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus].

  1994cited by this paper
• Mixed cryoglobulinemia and hepatitis C virus.

  1994cited by this paper
• Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma

  1994cited by this paper
• Lichen planus and hepatitis C virus--related chronic active hepatitis.

  1994cited by this paper
• Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

  1994cited by this paper
• Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection.

  1994cited by this paper
• Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia‐related syndrome

  1994cited by this paper
• Polyarthritis associated with hepatitis C virus infection.

  1994cited by this paper
• Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.

  1993cited by this paper
• High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

  1993cited by this paper
• Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda

  1993cited by this paper
• Hepatitis C virus and essential mixed cryoglobulinaemia.

  1993cited by this paper
• Non-organ specific autoantibodies associated with chronic C virus hepatitis.

  1993cited by this paper
• Hepatitis C virus and Sjögren's syndrome.

  1993cited by this paper
• Porphyria cutanea tarda and antibodies to hepatitis C virus

  1993cited by this paper
• HCV infection in porphyria cutanea tarda.

  1993cited by this paper
• Rheumatic manifestations of hepatitis C infection.

  1993cited by this paper
• Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa.

  1993cited by this paper
• Hepatitis C virus infection in type II mixed cryoglobulinemia.

  1993cited by this paper
• Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

  1993cited by this paper
• Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

  1992cited by this paper
• Characterization of cryoglobulins by immunoblotting.

  1992cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper
• Hepatitis C virus and Sjögren's syndrome.

  1992cited by this paper
• Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations.

  1992cited by this paper
• HCV and Sjögren's syndrome.

  1992cited by this paper
• Hepatitis C Virus Infection in Patients with Essential Mixed Cryoglobulinemia

  1992cited by this paper
• Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association

  1992cited by this paper
• Lichen planus and hepatitis C virus.

  1991cited by this paper
• Rheumatoid arthritis and hepatitis C virus antibodies.

  1991cited by this paper
• Prevalence of autoantibodies to thyroperoxidase in patients with various thyroid and autoimmune diseases.

  1991cited by this paper
• Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

  1980cited by this paper
• Biologic and clinical significance of cryoglobulins. A report of 86 cases.

  1974cited by this paper

• Chronic hepatitis C mortality in Brazil from 2000 to 2019: An analysis of multiple causes of death

  2025influential citation
• Autoantibody positivity in chronic hepatitis C pre- and post-direct-acting antiviral therapy: a prospective multicenter south Korean study

  2025cites this paper
• The global prevalence of co-occurrence of Sjögren syndrome and Hepatitis C virus infection: A systematic review and meta-analysis

  2025cites this paper
• Oral manifestations in patients with chronic hepatitis C

  2025cites this paper
• European Guideline on Chronic Pruritus

  2025cites this paper
• Care strategies for pregnant people and women living with hepatitis C in North America

  2025cites this paper
• Impact of HCV cure on systemic inflammation and bone density, quality, and turnover

  2025cites this paper
• Investigating the correlation between prominent viruses and hematological malignancies: a literature review

  2024cites this paper
• ReLink strategy in diagnosed-but-untreated hepatitis C-positive patients in Germany: report from a single center

  2024cites this paper
• Dysregulation of the Skin–Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis

  2024cites this paper
• 皮肤瘙痒的昼夜节律

  2024cites this paper
• Non‐liver‐related mortality in the DAA era: Insights from post‐SVR patients with and without previous HCC history

  2024cites this paper
• Non-infectious mixed cryoglobulinemia as a new clinical presentation of mutation in the gene encoding coatomer subunit alpha: a case report of two adult sisters

  2024cites this paper
• Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C Patients

  2024cites this paper
• A case of diffuse large B‐cell lymphoma with decompensated alcohol‐related liver cirrhosis treated successfully by chemoimmunotherapy

  2024cites this paper
• A multicentric and nationwide predictive study role of T cell sub‐population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients

  2023cites this paper
• CLEC18A Impairs Phagocytosis by Reducing FcγRIIA Expression and Arresting Autophagosome-Lysosome Fusion

  2023cites this paper
• Persistent pruritus associated with worse quality of life in patients with chronic hepatitis

  2023cites this paper
• Bidirectional Association between Lichen Planus and Hepatitis C—An Update Systematic Review and Meta-Analysis

  2023cites this paper
• Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model

  2023cites this paper
• Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States

  2023cites this paper
• Incidence and risk factors of extrahepatic manifestations in patients with chronic HCV and HCV/HIV infection

  2022cites this paper
• Morphological Changes in the Oral Mucous Membrane in Viral Hepatitis C Patients: A Cross-Sectional Study

  2022cites this paper
• Lung Function in Women With and Without Human Immunodeficiency Virus

  2022cites this paper
• Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

  2022cites this paper
• Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease

  2022cites this paper
• Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection

  2022cites this paper
• Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations

  2022cites this paper
• Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients

  2022cites this paper
• MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication

  2022cites this paper
• HLA-DRB1 polymorphisms and rheumatologic manifestations in chronic hepatitis C.

  2022cites this paper
• Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus

  2022cites this paper
• Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR

  2022cites this paper
• Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection

  2022cites this paper
• A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection

  2022cites this paper
• Impact of HCV Infection on Hepatocyte Polarity and Plasticity

  2022cites this paper
• Direct-Acting Antiviral Therapy Effect on Extrahepatic Rheumatic Manifestations in Egyptian Chronic Hepatitis C (HCV) Patients

  2021cites this paper
• Is the Frequency of Hepatitis B Virus and Hepatitis C Virus Infection Increased in Patients with Lichen Planus?

  2021cites this paper
• Factors Related to Sleeping Disorder Due to Pruritus in Patients with Chronic Liver Disease

  2021cites this paper
• Viral hepatitis: Milestones, unresolved issues, and future goals

  2021cites this paper
• Incidental case of primary renal lymphoma (PRL) in a patient with chronic hepatitis C infection. Report of a rare case

  2021cites this paper
• Hepatic pathological features in naïve patients with chronic hepatitis C who have developed thyroid disorder

  2021cites this paper
• Tubular cell damage may be the earliest sign of renal extrahepatic manifestation caused by Hepatitis C

  2021cites this paper
• Assessment and classification of chronic pruritis and its relation to systemic diseases

  2021cites this paper
• Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride

  2021cites this paper
• Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A Nationwide Population-Based Cohort Study

  2021cites this paper
• Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor

  2021cites this paper
• Musculoskeletal Manifestations and Bone Mineral Density in Chronic Hepatitis C Patients

  2021cites this paper
• Human hepatitis viruses-associated cutaneous and systemic vasculitis

  2021cites this paper
• Genetic rhabdomyolysis within the spectrum of the Spinocerebellar Ataxia type 2 responsive to pregabalin

  2021cites this paper
• Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents

  2021cites this paper
• Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics

  2020cites this paper
• Hepatitis C virus associated skin manifestations in upper Egypt: Before and after direct acting antiviral treatment

  2020cites this paper
• THE RELATIONSHIP OF SERUM AMINOTRANSFERASES WITH SODIUM AND CREATININE AND THEIR ASSOCIATION WITH INTERDIALYTIC WEIGHT GAIN (IDWG)

  2020cites this paper
• Subclinical hepatitis C virus infection in Egyptian patients with rheumatic diseases: a multi-center study

  2020cites this paper
• Quantification of plasma levels of antiviral drug sofosbuvir and its metabolite GS331007 in patients of chronic hepatitis C with chronic kidney disease using UPLC-MS/MS method

  2020cites this paper
• Prevalence and Determinants of Kidney Markers among Subjects with Hepatitis C Virus Infection

  2020cites this paper
• Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis

  2020cites this paper
• Cryoglobulinemic vasculitis: pathophysiological mechanisms and diagnosis

  2020cites this paper
• Successful fourth line treatment of a relapse patient with chronic hepatitis C virus infection genotype 3a using sofosbuvir, glecaprevir/pibrentasvir, and ribavirin: a case report

  2020cites this paper
• Analysis of socioeconomic status and other factors affecting patient-graft survival in patients undergoing liver transplantation

  2020cites this paper
• Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach.

  2020cites this paper
• Interferon-based therapy did not attenuate hepatitis C-associated rheumatic disorder risk: A nationwide population-based cohort study

  2020cites this paper
• Human platelet antigen-3 polymorphism as a risk factor for rheumatological manifestations in hepatitis C

  2020cites this paper
• Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C

  2020cites this paper
• Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult.

  2020cites this paper
• Cryoglobulin induced vasculitis as the first clinical presentation of a patient with light chain myeloma – a case report

  2020cites this paper
• The role of dentists in controlling hepatocellular carcinoma in Japan (Review)

  2020cites this paper
• Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

  2020cites this paper
• PATIENT ENCOUNTER RESOURCE PACKET FOR PRESCRIBERS EVALUATING PERSONS WITH HEPATITIS C VIRUS (HCV) FOR HCV TREATMENT

  2020cites this paper
• Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.

  2019cites this paper
• Association of diabetes mellitus with hepatitis B and hepatitis C virus infection: evidence from an epidemiological study

  2019cites this paper
• Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection

  2019cites this paper
• A Recurrent Case of Cryoglobulin-related Leukocytoclastic Vasculitis with an Unexpected Etiology

  2019cites this paper
• Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins.

  2019cites this paper
• Carbazole Derivatives as Antiviral Agents: An Overview

  2019cites this paper
• Von Hauteffloreszenzen zum pulmorenalen Syndrom

  2019cites this paper
• Hepatitis C Virus Infection and Renal Disorders

  2019cites this paper
• Possible Molecular Mediators Involved and Mechanistic Insight into Fibromyalgia and Associated Co-morbidities

  2019cites this paper
• HCV Extrahepatic Manifestations

  2019cites this paper
• IS HEPATITIS C LIKE A HOT KNIFE THROUGH BUTTER (A SILENT KILLER).

  2019cites this paper
• THE ROLE OF HYDROXYCHLOROQUINE AS MONOTHERAPY IN MANAGING EARLY UNDIFFERENTIATED ARTHRITIS: A PROSPECTIVE HOSPITAL-BASED STUDY

  2019cites this paper
• Seeking markers to distinguish HCV-Infected-autoimmune subjects from uninfected-autoimmune patients

  2019cites this paper
• Understanding the Cryoglobulinemias

  2019cites this paper
• Persistence of Cryoglobulinemia in Patients with Chronic Hepatitis C after Successful Treatment with Direct-acting Antivirals

  2019cites this paper
• Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis

  2019cites this paper
• Infection phase is a predictor of pruritus in patients with hepatitis B virus infection

  2019cites this paper
• Clinical Characteristics of HCV in Egyptian Patients

  2019cites this paper
• Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study

  2019cites this paper
• Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study

  2018cites this paper
• Efficacy and safety of sofosbuvir-based, interferon-free therapy

  2018cites this paper
• Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database

  2018cites this paper
• HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases

  2018cites this paper
• Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France

  2018cites this paper
• Prevalence of pruritus in patients with chronic liver disease: A multicenter study

  2018cites this paper
• Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients

  2018cites this paper
• High prevalence of a variety of autoantibodies in a population of hepatitis C virus‐infected individuals

  2018cites this paper
• Von Hauteffloreszenzen zum pulmorenalen Syndrom

  2018cites this paper
• Hepatitis C virus infection in chronic kidney disease: paradigm shift in management

  2018cites this paper
• Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis

  2018cites this paper